Please refer attachment

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-8.9%Reaction day

₹40.75

prior close

₹40.15

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.7%-6.2% vs market

Commodity Chemicals peers, median of 51sector-3.0%-5.9% vs sector

On the reaction day the stock moved 6.2 pts less than Nifty Microcap 250 and 5.9 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.9

10m

-0.5

15m

-2.9

30m

-2.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-8.9-2.7-6.2-3.0-5.9

Next day

-11.9-2.7-9.2-2.9-9.0

-8.3-2.8-5.5-3.3-5.0

-14.1-4.9-9.2-5.7-8.4

-15.0-5.0-10.0-5.2-9.7

-18.7-3.6-15.1-4.4-14.3

-11.4-5.0-6.4-6.0-5.3

15d

-16.6+4.8-21.3-1.5-15.0

-14.1+5.6-19.8-0.2-13.9

-18.2+8.3-26.4+4.7-22.9

-19.3+8.8-28.1+6.6-25.9

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 51Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Emmessar Biotech & Nutrition Ltd (BSE: 524768) declared its audited standalone results for FY25 along with Q4 FY25 numbers. Revenue from operations rose to Rs. 61.09 lakhs from Rs. 55.52 lakhs in FY24, a growth of about 10%. Total income grew modestly to Rs. 261.96 lakhs from Rs. 254.73 lakhs. Profit before tax improved to Rs. 95.82 lakhs from Rs. 81.26 lakhs. However, net profit after tax fell sharply to Rs. 31.61 lakhs from Rs. 65.11 lakhs, mainly because total tax expense jumped to Rs. 64.20 lakhs from Rs. 16.15 lakhs. Basic EPS dropped to Rs. 0.61 from Rs. 1.28. Q4 FY25 alone slipped into a loss of Rs. 6.86 lakhs against a profit of Rs. 27.00 lakhs in Q4 FY24. The statutory auditor V. Nagarajan & Co. issued an unmodified (clean) audit opinion, and no investor complaints were pending.

Likely market impact

Despite better revenue and pre-tax profit, the steep drop in full-year PAT and EPS, plus a Q4 loss, is negative for shareholders. The clean audit opinion is reassuring, but the heavy tax outflow is the main drag on bottom-line performance.